Wednesday, July 8, 2026

Drug profile · INN

echothiophate iodide

echothiophate iodide (PHOSPHOLINE IODIDE) is a acetylcholinesterase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — echothiophate iodide
US status
approved
Class
Route
OPHTHALMIC
Patents
0
Programs
0
Data quality
0.84

Quick answer

echothiophate iodide (PHOSPHOLINE IODIDE) is a acetylcholinesterase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN echothiophate iodide
Brand PHOSPHOLINE IODIDE
Mechanism Acetylcholinesterase inhibitor
Target Acetylcholinesterase
Route OPHTHALMIC
Formulation FOR SOLUTION

Mechanism of action

Acetylcholinesterase inhibitor

Primary target: Acetylcholinesterase

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. benzgalantamine gluconate Acetylcholinesterase inhibitor
  2. donepezil hydrochloride Acetylcholinesterase inhibitor
  3. neostigmine methylsulfate Acetylcholinesterase inhibitor
  4. pyridostigmine bromide Acetylcholinesterase inhibitor
  5. ambenonium chloride Acetylcholinesterase inhibitor
  6. demecarium bromide Acetylcholinesterase inhibitor

Frequently asked questions

What is echothiophate iodide?

echothiophate iodide (PHOSPHOLINE IODIDE) is a acetylcholinesterase inhibitor. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for echothiophate iodide?

PHOSPHOLINE IODIDE is a marketed brand name for echothiophate iodide. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of echothiophate iodide?

echothiophate iodide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.